Cell Port Clinic

Cellport Clinic Yokohama is a specialist aesthetic medicine and cosmetic surgery clinic located in the Naka ward of Yokohama, Japan's second-largest city and a major international port city immediately adjacent to Tokyo. The clinic positions itself at the intersection of conventional cosmetic surgery and advanced cell-based aesthetic therapies, offering patients access to cosmetic surgical procedures alongside innovative treatments that utilize the patient's own autologous adipocytes (fat cells) and their cellular components.

The clinic's approach begins with listening carefully to each patient's specific wishes and concerns, then designing a personalized treatment plan that delivers the most appropriate clinical solution. This patient-centred consultation methodology — which the clinic describes as the foundation of successful aesthetic medicine — ensures that every patient's treatment is individually tailored rather than following a standard protocol, and that realistic, achievable outcomes are clearly communicated from the outset.

The clinic's distinctive clinical strength lies in its dedicated adipocyte cell processing capabilities. Cellport Clinic has invested in the specialized medical equipment and cell processing laboratory facilities required to perform advanced fat-derived cell therapies — treatments that use cells harvested from the patient's own adipose tissue (fat) as therapeutic agents. These adipocyte-derived cell treatments occupy a sophisticated position in aesthetic medicine, offering regenerative and volumizing effects beyond what conventional cosmetic procedures can achieve, while using the patient's own biological material to maximize safety and biocompatibility.

Yokohama's central Naka ward location offers excellent access from central Tokyo (approximately 30 minutes by train from Shibuya) and from Yokohama Station. The clinic's premises at Yokohama Excellent III on Minaminakadori provide a central, easily navigable location for patients from Tokyo, Yokohama, and further afield, including international patients who visit Japan for cosmetic and aesthetic medicine.

Cellport Clinic Yokohama offers a dual portfolio of conventional cosmetic surgery and advanced autologous cell therapy procedures.

Conventional cosmetic surgery services include facial rejuvenation procedures (facelift, brow lift, blepharoplasty/eyelid surgery including double-eyelid surgery, rhinoplasty), body contouring (liposuction, abdominoplasty, arm lift), and breast surgery (augmentation with implants, reduction, mastopexy). Non-surgical aesthetic treatments including Botox, hyaluronic acid fillers, and skin rejuvenation procedures are also available.

The clinic's specialized cell therapy program uses autologous adipocyte cells harvested from the patient's own fat tissue. The harvested adipose tissue is processed in the clinic's specialized cell processing facility to isolate and concentrate specific cellular fractions — including adipose-derived stem cells (ADSCs) and mature adipocytes — which are then used therapeutically for volumizing and regenerative facial and body treatments. This approach enables autologous fat transfer with cell enrichment, offering potentially superior volume retention and regenerative effects compared to conventional structural fat grafting alone.

Autologous fat transfer (fat grafting) with and without cellular enrichment is used for facial volume restoration (cheeks, temples, jawline, lip augmentation), hand rejuvenation, breast augmentation as an alternative to implants, and body contour correction. Treatments using adipocyte-derived cellular fractions for skin quality improvement and regenerative applications represent the clinic's most advanced cell therapy offerings.

Pre-treatment consultation and assessment includes clinical photography, detailed patient history review, skin assessment, and a thorough discussion of treatment goals and expected outcomes before any procedure is planned or scheduled.

Cellport Clinic Yokohama is located at Yokohama Excellent III, 2nd Floor, 3-35 Minaminakadori, Naka-ku, Yokohama, Kanagawa Prefecture. The clinic is purpose-equipped for both cosmetic surgical procedures and for the specialized cell processing activities that support its adipocyte cell therapy program.

The clinical facility includes modern consultation and examination rooms, a surgical procedure suite equipped for cosmetic surgical operations under local or sedation anesthesia, and recovery areas for post-procedure patient care. The treatment room environment is designed to provide a comfortable, professional, and private experience consistent with the standards expected of a premium Japanese aesthetic clinic.

The clinic's most distinctive physical infrastructure is its cell processing facility — a specialized laboratory space equipped with the medical-grade cell processing equipment, incubators, centrifuges, and sterile handling systems required for the safe processing of patient adipose tissue and the preparation of autologous cellular fractions for therapeutic use. This on-site cell processing capability enables the clinic to perform same-day or closely timed harvest-process-transfer procedures, maintaining the cellular viability required for effective cell therapy.

All clinical and cell processing procedures follow strict sterility and infection prevention protocols appropriate to medical cell therapy applications. Japanese Ministry of Health, Labour and Welfare guidelines for cell therapy products and their clinical use are adhered to throughout the cell processing and treatment delivery process.

Cellport Clinic Yokohama is accessible to international patients and medical tourists who are interested in Japan's advanced aesthetic medicine sector. Japan has gained recognition globally not only for high-technology hospital-based medicine but also for the precision, care standards, and innovation characteristic of its specialist aesthetic medical clinics. Cellport's combination of conventional cosmetic surgery and proprietary cell therapy offers international patients access to advanced aesthetic procedures that may not be available in their home countries.

Yokohama Naka ward is easily accessible from central Tokyo — approximately 30 minutes by train from Shibuya on the Tokyu Toyoko Line — and from both Narita International Airport and Haneda Airport via rail or road transfer. The central Minaminakadori location is walkable from Yokohama's central station area and is well served by the city's public transport network.

Initial consultations can be arranged in advance for international patients. The clinic's commitment to careful patient consultation and individualized treatment planning applies equally to international and domestic patients. All treatment recommendations, procedure explanations, and post-treatment care instructions are provided with patient comprehension as the primary objective. International patients are encouraged to allow adequate recovery time in Japan following surgical procedures before returning home.

Yokohama itself offers a distinctive visitor experience — as Japan's historic international port city, it has a cosmopolitan character with numerous international restaurants, waterfront attractions, and easy access to Tokyo's cultural and commercial offerings during the recovery period.

Cellport Clinic Yokohama operates as a licensed medical institution under Japanese national regulatory standards. All physicians at the clinic hold Japanese medical licensure issued by the Ministry of Health, Labour and Welfare (MHLW), and practice in compliance with the Medical Care Act (医療法), which governs all licensed medical facilities in Japan, including clinical aesthetics clinics.

The clinic's cell therapy activities — involving the processing and clinical application of autologous adipocyte cells and their fractions — are conducted in compliance with the Japanese Act on the Safety of Regenerative Medicine (再生医療等の安全性の確保等に関する法律, Regenerative Medicine Safety Act), enacted in 2014. This legislation specifically regulates the clinical application of processed autologous and allogeneic cells in Japan, requiring registered providers to follow approved protocols, maintain appropriate cell processing infrastructure, and report clinical outcomes. Compliance with this specialized regulatory framework reflects the clinical seriousness with which the clinic's cell therapy program is managed.

All medical devices, cell processing equipment, and materials used at the clinic comply with Japanese pharmaceutical and medical device regulatory requirements administered by the Pharmaceuticals and Medical Devices Agency (PMDA). The clinic maintains comprehensive clinical records and patient consent documentation appropriate to both conventional cosmetic surgery and cell therapy procedures.